Dr. Dawn E. Kingston PhD
Dr. Dawn Kingston is an Associate Professor at the University of Calgary. She holds the Lois Hole Hospital for Women Cross-Provincial Chair in Perinatal Mental Health and is a CIHR New Investigator.
Dr. Kingston and her team are passionate about helping women and their families have the best start to life by improving maternal mental health, especially during pregnancy. She and her team develop and evaluate approaches for screening and treating women who struggle with depression and anxiety during pregnancy. They are leading the field in using e-technology for screening and therapy in pregnant women so that women can get help whenever they need it, wherever they are. Their nationally-funded trials are among the first to explore the clinical- and cost-effectiveness of e-screening and e-therapy on the mental health of pregnant women, and how this early intervention impacts the mental health, physical health and development of their children. Dr. Kingston’s team also studies the mental health needs of women and men undergoing infertility treatment and is beginning to design and evaluate mental health e-screening and e-therapy for this group.
The team enjoys collaborating with other experts worldwide as it seeks to improve women’s mental health and children’s outcomes globally. Dr. Kingston also values her strong collaborations with Alberta’s only women’s hospital, the Lois Hole Hospital for Women, as she and her team implement and evaluate “scaled up” e-screening and e-therapy interventions in acute care areas, including the high risk antenatal unit and the regional infertility clinic.
Dr. Kingston and Dr. Radha Chari are co-leading Canada’s first consensus statement in perinatal mental healthcare. In collaboration with the Society of Obstetricians and Gynecologists of Canada, the Canadian Psychiatric Association, and the Royal Australian and New Zealand College of Obstetricians, this guideline will set Canada’s first standards of care for mental health screening of pregnant and postpartum women.
1. I have/had an affiliation (financial or otherwise) with a pharmaceutical, medical device or communications organization:
2. I have received payment from a commercial organization (including gifts or other consideration or ‘in kind’ compensation): Shopper's Drug Mart
3. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).